US physicians could end vaccinations

8 December 2008

Over one in five (21%) family physicians polled in a US survey has seriously considered ending vaccinations for privately-insured patients, the Associated Press reports. Even in the case of pediatricians, the figure is 5%, although one of them, Herschel Lessin, told the AP: "for us to give up vaccines would hurt our core business, because that's why kids come in."

The threat of vaccine boycotts by doctors is not based on safety concerns or even a religious objection to immunization procedures. Instead, University of Michigan researcher Gary Freed, co-author of two studies on the issue, found that poor reimbursement levels are to blame. The data indicated that one in 10 physicians takes a loss when administering a child vaccine. Meanwhile, the variation in insurance payments to doctors for each dose of pneumococcal disease vaccine can range from an $11 loss to a $40 profit.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK